AKANAKANDA CORP.vs its industry peers
A metric-by-metric comparison of AKANDA CORP. against Medicinal Chemicals & Botanical Products — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AKAN본 종목 | $6M#3 | — | — | 7.2x#5 | 97.5%#3 | 87.3%#4 | -523.8%#12 | — | — | — | -96.2%#7 | — |
| CYAN | $3M#5 | — | 0.4x#2 | 0.1x#2 | 5.0%#5 | 39.2%#6 | -10.4%#6 | -39.7%#3 | -15.9%#4 | 5#1 | 0.0%#1 | — |
| MEHA | $1M#7 | — | — | 0.2x#3 | 0.7%#6 | 235.6%#2 | -21.2%#7 | — | — | — | — | — |
| SNYR | $1M#6 | — | — | 0.0x#1 | -12.8%#10 | -680.8%#13 | -27.8%#8 | — | — | 2#6 | -92.6%#6 | 84.7%#1 |
| AAWH | — | — | — | — | -10.9%#9 | -39.1%#10 | -3.4%#3 | — | -10.3%#3 | — | — | — |
| ACB | $227M#2 | — | — | — | — | — | — | — | — | — | -20.8%#2 | — |
| ADIA | — | — | — | — | 10879.7%#1 | -118.4%#11 | -52.3%#10 | — | — | — | — | — |
| AIBT | — | — | — | — | — | -19.9%#8 | -84501.7%#13 | — | — | — | — | — |
| AYRWF | — | — | — | — | 0.0%#7 | -31.9%#9 | -34.7%#9 | -94.7%#4 | -21.8%#6 | 4#3 | — | — |
| BON | $5M#4 | — | 0.1x#1 | 0.3x#4 | -21.7%#11 | -601.0%#12 | -8.7%#4 | -3.5%#2 | -2.4%#2 | 4#3 | -38.9%#4 | — |
| BTMD | — | 9.5x#1 | — | — | -2.5%#8 | 756.7%#1 | 18.5%#1 | — | 67.1%#1 | — | -57.9%#5 | — |
| CBDY | — | — | — | — | -41.1%#12 | -947.1%#14 | 1.3%#2 | — | — | 3#5 | — | — |
| CFOO | — | — | — | — | 40.5%#4 | 12.5%#7 | -121.7%#11 | — | — | — | — | — |
| CGC | $391M#1 | — | — | — | — | 46.6%#5 | — | — | — | — | -32.9%#3 | — |
| CHUC | — | — | — | — | 169.4%#2 | 208.2%#3 | -10.4%#5 | 143.5%#1 | -21.1%#5 | 5#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2833). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-22.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice